Company intelligence / Profile preview

ISISPHARMA

Wasquehal, Hauts-de-France, France
Ownership
Private
Employees
~159
Development stage
Other
01

Overview

Isispharma is a French pharmaceutical laboratory specializing in dermatology and skincare solutions. Founded in 1987 by pharmacist Christian Diehl, the company focuses on the concept of skin homeostasis to restore the skin's natural balance. Their product portfolio addresses a wide range of dermatological conditions, including hyperpigmentation, rosacea, acne, and vitiligo. Isispharma operates as part of the Dewavrin Group and distributes its products in over 80 countries. The company emphasizes clinical research and collaborates closely with healthcare professionals to develop effective dermo-cosmetic treatments. Their core brands, such as Neotone and Ruboril, are widely recognized for their targeted efficacy and safety profiles.

Therapeutic areas
Dermatology
Modalities
CosmeticEmollientPlant extractTopical
Industry
Biotech
02

Drug pipeline

1 asset

Neotone serum

Unknown
03

Partnerships

CNRS (French National Center for Scientific Research)

Beyond the preview

Go deeper on ISISPHARMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISISPHARMA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call